Control
Participants in the control group received usual general practitioner led care, which could range from visits purely in response to individual requests to regular weekly sessions to provide more proactive care. Pharmacist provision could range from provision of medicines only (by a community pharmacist) to three, six, or 12 monthly visits by primary care based pharmacists doing medication reviews. Few, if any, of these reviews would have involved pharmacists actively prescribing, as opposed simply to providing advice to the general practitioner. PIPs recruited and trained within the trial had no interaction with control homes.